论文部分内容阅读
随着社会的进步和文化水平的提高,青少年近视眼的患病率有不断增加的趋势。近视眼的防治问题引起普遍重视,各种治疗方法也应运而生。重庆医学工业研究所研制的0.25％托吡卡胺眼药水(双星明)经临床应用,证实具有散瞳和麻痹睫状肌的作用,对调节性近视有明显疗效。但对不同浓度托吡卡胺眼药水治疗近视眼效果及影响疗效因素的研究尚未见报道。为此我们对太原市某中学初中一年级学生进行了这两方面的观察,以便更科学地评价托吡卡胺眼药水的疗效,探讨保护视力新的有效途径。1 对象与方法1·1 对象及分组1·1.1 对象;选取远视力在.0～5.0之间,两眼视力差小于0.3,近视力≥5.0,近视屈光度(小瞳验光)在-4.50D及以下的轻、中
With the progress of society and the improvement of the educational level, the prevalence of myopia in teenagers is on the rise. Prevention and treatment of myopia caused widespread attention, a variety of treatment methods have also emerged. Chongqing Medical Industry Research Institute developed 0.25% tropicamide eye drops (Shuangxing Ming) clinical application, confirmed that the role of mydriasis and paralysis of the ciliary muscle, a clear effect on regulatory myopia. However, different concentrations of tropicamide eye drops for the treatment of myopia and the effect of factors affecting the study has not been reported. To this end, we conducted a first-year middle school students in a high school in Taiyuan two aspects of these observations in order to more scientific evaluation of tropicamide eye drops efficacy and explore new effective ways to protect eyesight. 1 objects and methods 1.1 objects and groups 1 1.1 objects; selected far vision in the 0 ~ 5.0 between the two visual acuity difference is less than 0.3, myopia ≥ 5.0, myopic refraction (pupil optometry) at -4.50D and The following light, medium